• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Cytosorbents Corporation (CTSO)

    -NasdaqCM
    3.70 Down 0.25(6.33%) Feb 5, 4:00PM EST
    Prev Close:3.95
    Open:3.96
    Bid:N/A
    Ask:10.19 x 300
    1y Target Est:17.06
    Beta:0.059328
    Earnings Date:Mar 29 - Apr 4 (Est.)
    Day's Range:3.58 - 4.04
    52wk Range:3.50 - 15.24
    Volume:127,460
    Avg Vol (3m):88,310
    Market Cap:93.85M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for CTSO

    Comparison

    Symbol% ChgMkt Cap
    CTSODown 6.33%93.85M
    LLYUp 0.05%78.70B
    BAXDown 2.09%20.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.66
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.33
    Quarterly EPS Est (Dec-15) :-0.08
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback